Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Chelating drug to be codeveloped by Biomedical Frontiers and Chiesii

March 2, 2001

Therapeutic agents for drug addiction, withdrawal, etc., claimed by Knoll

Feb. 22, 2001

CroFab now available in the U.S. for treatment of poisonous snakebites

Feb. 1, 2001

Anticocaine catalytic MAb selectively attenuates cocaine selfadministration in rats

Jan. 9, 2001

FDA approves second indication for Antizol

Dec. 13, 2000

Antizol approved in Canada for treatment of ethylene glycol poisoning

Dec. 6, 2000

Novel, orally active iron chelator APO-363: preclinical pharmacokinetics reported at AAPS

Nov. 7, 2000

NIDA grant awarded to Nabi for nicotine vaccine research

Oct. 10, 2000

Alkermes completes patient enrollment in clinical trial of new treatment for alcoholism

Oct. 3, 2000

Stimulation of brain reward areas by nicotine causes addiction

Aug. 31, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.